0001193125-22-182709.txt : 20220728 0001193125-22-182709.hdr.sgml : 20220728 20220627143853 ACCESSION NUMBER: 0001193125-22-182709 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 CORRESP 1 filename1.htm CORRESP

RAPT Therapeutics, Inc.

561 Eccles Avenue

South San Francisco, California, 94080

June 27, 2022

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: Joshua Gorsky

 

Re:

RAPT Therapeutics, Inc.

Registration Statement on Form S-3 Filed June 24, 2022

File No. 333-265812

To whom it may concern:

Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, RAPT Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-265812) be accelerated by the Securities and Exchange Commission to 4:00 p.m. Washington D.C. time on June 29, 2022 or as soon as practicable thereafter.

The Company requests that we be notified of such effectiveness by a telephone call to Courtney M.W. Tygesson of Cooley LLP at (312) 881-6500 and that such effectiveness also be confirmed in writing.

 

Very truly yours,
RAPT Therapeutics, Inc.
By:  

/s/ Rodney Young

  Rodney Young
  Chief Financial Officer

 

cc:

Courtney M.W. Tygesson, Cooley LLP